期刊文献+

癌基因ras对β-1,4-半乳糖基转移酶活性的调节 被引量:2

The Regulation of Activity of β-1,4-Galactosyltransferase by Oncogene ras
下载PDF
导出
摘要 研究癌基因ras对细胞表面的 β 1,4 半乳糖基转移酶活性的调节 构建Ha ras表达载体并转染NIH 3T3细胞株 ,测定细胞表面和细胞内 β 1,4 半乳糖基转移酶活性和其mRNA的水平 结果发现ras使NIH 3T3细胞表面的 β 1,4 半乳糖基转移酶活性降低 ,而高尔基体内的活性不变 此外用Northern印迹检测后发现 ,ras不能改变细胞内 β 1,4 半乳糖基转移酶的mRNA水平 这说明癌基因ras能够调节细胞表面β 1,4 半乳糖基转移酶活性 。 In order to investigate the regulation of β 1,4 galactosyltransferase (GalTase) activity by oncogene Ha ras , expression vector of oncogene Ha ras was constructed and transfected into NIH 3T3 cell line. The activities of cell surface and total GalTase activity were assayed by HPLC method. The mRNA of GalTase activity was also evaluated by Northern blot. It was found that the activity of cell surface GalTase was decreased by ras transfection and the enzyme activity of Golgi apparatus remained constant. The mRNA level of GalTase does not be changed by ras . The results showed that the activities of GalTase might be regulated by Ras signal pathway.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2001年第4期529-532,共4页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金 (No 39870 16 80 )资助&&
关键词 Β-1 4-半乳糖基转移酶 癌基因 HA-RAS 酶活性调节 β-1,4-galactosyltransferase (GalTase), Ha ras ,regulation of activity
  • 相关文献

参考文献2

同被引文献25

  • 1Narimatsu H. Human glycogene cloning: focus on 133- glycosyhransferase and β4-glycosyltransferase families [ J ]. Curr Opin Struct Biol, 2006, 16(5): 567-575.
  • 2Hiroyasu I, Akira T, Tokiko S, et al. A novel betal, 3-N- acetylglucosaminyltransferase ( beta3Gn-T8 ) , which synthesizes poly-N-aeetyllactosamine, is dramatically upregulated in colon cancer[J]. FEBS Lett, 2005, 579(1): 71-78.
  • 3Seko A, Yamashita K. Characterization of a novel galactose: β- 1,3-N-acetylglucosaminyltransferase ( 133Gn-T8 ) : the complex formation of 133Gn-T2 and 133Gn-T8 enhances enzymatic activity [J]. Glycobiology, 2005, 15(10): 943-951.
  • 4Maroulakou I G, Bowe D B. Expression and function of Ets transcription factors in mammalian development: a regulatory network[J]. Oncogene, 2000, 19(55): 6432-6442.
  • 5Seth A, Watson D K. ETS transcription factors and their emerging roles in human cancer[ J]. Eur J Cancer, 2005, 41 (16) : 2462-2478.
  • 6Qiu H, Wu S L, Guo X H, et al. Expression of β1, 3-N- acetylglueosaminyltransferases during differentiation of human acute myeloid leukemia cells[ J]. Mol Cell Biochem, 2011, 358 (1-2) :131-139.
  • 7Ko J H, Miyoshi E, Noda K, et al. Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines [J]. J Biol Chem, 1999, 274(33): 22941-22948.
  • 8Kang R, Saito H, Ihara Y, et al. Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells ( HuCC-T1 ) is mediated by Ets-1 [ J]. J Biol Chem, 1996, 271(43): 26706-26712.
  • 9Sato T, Furukawa K. Sequential action of Ets-1 and Spl in the activation of the human beta-1, 4-galactosyl transferase V gene involved in abnormal glycosylation characteristic of cancer ceils [J]. J Biol Chem, 2007, 282(38): 27702-27712.
  • 10Sato T, Furukawa K. Transcriptional regulation of the human β- 1,4-galactosyltranferase V gene in cancer ceils, Essential role oftranscription factor Spl [ J]. J Biol Chem, 2004, 279 ( 38 ) : 39574-39583.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部